This study is currently not recruiting participants.

30-day open-label active-controlled randomized study of the safety efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in young children with various manifestations of venous thrombosis

Study on the Safety and Effects of an Investigational Medication

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to assess the safety and efficacy of rivaroxaban and also to evaluate the pharmacokinetics and pharmacodynamics of rivaroxaban.

Detailed description of study

The purpose of this study is to assess the safety and efficacy of rivaroxaban and also to evaluate the pharmacokinetics and pharmacodynamics of rivaroxaban.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: venous thrombosis
  • Age: 100 years or below
  • Gender: All

This study investigates the safety and effectiveness of an investigational medication. It aims to understand how the medication works in the body and its effects.

Participants will undergo various procedures to monitor how the investigational medication is processed in the body and its impact on health.

  • Who can participate: Participants must meet specific eligibility criteria, including age range and health status, which will be provided upon inquiry.
  • Study details: Participants will undergo various procedures to monitor how the investigational medication is processed in the body and its impact on health. A placebo is not mentioned in this study.
Updated on 19 Feb 2024. Study ID: 1409115242

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team